Dutch medical technology firm Philips reported a stronger-than-expected third-quarter profit, driven by the successful rollout of its new AI-powered tools and effective measures to offset the impact of tariffs.
Adjusted EBITA rose to €531 million, exceeding analyst forecasts of €484 million. Revenue increased 3% to €4.3 billion ($5 billion), in line with expectations, supported by robust demand in North America.
The company, which generates a majority of its sales in the U.S., also noted that the impact of American tariffs was lower than anticipated, helping bolster overall performance.